Jun 24 |
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine
|
Jun 24 |
Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?
|
Jun 21 |
Top Analyst Reports for Abbott, BP & Gilead
|
Jun 20 |
Is Abbott Laboratories (ABT) a Strong Buy Right Now?
|
Jun 20 |
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
|
Jun 20 |
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
|
Jun 17 |
New Weight-Loss Drugs and Devices Are Coming This Week
|
Jun 17 |
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
|
Jun 14 |
Abbott Declares 402nd Consecutive Quarterly Dividend
|
Jun 13 |
FDA must fix “inadequate” inspection and recall policies, report says
|